-
Collaboration is imperative to accessible design
Back in March, I wrote about how living with Duchenne muscular dystrophy (DMD) has shaped
-
Experimental drug del-brax curbs signs of muscle damage in FSHD: Study
The experimental medication delpacibart braxlosiran (del-brax) reduced biological markers of facioscapulohumeral muscular dystrophy (FSHD) disease








